SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

Press Releases Sun Pharma Advanced Research Company Limited

Equities

SPARC

INE232I01014

Market Closed - NSE India S.E. Other stock markets 07:43:55 2024-07-11 am EDT			5-day change	1st Jan Change
237.8 ^INR	-0.78%		-2.12%	-17.09%

May. 24	Sun Pharma Advanced Research Company Limited Announces Chief Financial Officer Changes	CI
May. 24	Sun Pharma Advanced Research Company Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ocular Hypertension Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 \| Nicox, Qlaris Bio, TheratOcular Biotek Co., Ltd., Ocular Therapeutix, Whitecap Biosciences, and others.	Dec. 06	AQ
Sun Pharma Advanced Research : Update on Clinical Programs and R&D Pipeline	Nov. 02	PU
Sun Pharma Advanced Research : SPARC enters into an exclusive worldwide license agreement for SCD-153 with JHU and IOCB	Nov. 02	PU
Sun Pharma Advanced Research : SPARC Completes Enrolment in PROSEEK, A Global Phase 2 Study of Vodobatinib in Early Parkinson’s Disease	23-10-30	PU
Sun Pharma Advanced Research : SPARC to Provide Update on Clinical Programs and R&D Pipeline	23-10-19	PU
Sun Pharma Advanced Research : AGM Speech 2022-23	23-08-07	PU
Sun Pharma Advanced Research : FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility	23-07-13	PU
Sun Pharmaceutical Industries Limited - SEZABY approved by US FDA for the treatment of neonatal seizures	22-11-21	AQ
Sun Pharma Advanced Research : SEZABY™ (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures	22-11-17	PU
Sun Pharma Advanced Research : and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US	22-11-09	PU
Sun Pharma Advanced Research : Outcome of committee meeting	22-11-08	PU
Sun Pharma Advanced Research : Investors presentation press release_29th Sept 2022	22-09-29	PU
Sun Pharma Advanced Research : AGM Speech 2021-22	22-09-22	PU
Sun Pharma Advanced Research : FY 2021-22	22-08-30	PU
Sun Pharma Advanced Research : Corporate Presentation	22-07-08	PU
Sun Pharma Advanced Research : Outcome of committee meeting	22-03-21	PU
Sun Pharma Advanced Research : Corporate Presentation	21-12-28	PU
Sun Pharma Advanced Research : SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting	21-12-10	PU
Sun Pharma Advanced Research : Update on SPARC strategy and portfolio	21-12-09	PU
Sun Pharma Advanced Research : SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma	21-12-07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sun Pharma Advanced Research Company Limited

Equities

SPARC

INE232I01014

Press Releases

Filters